Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,619.00    -20.00 (-0.76%)
Bid:
2,621.00
Ask:
2,625.00
Spread: 4.00 (0.153%)
Market Cap: £23.39b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Chair appointment

21 Apr 2026 07:00

RNS Number : 2049B
Experian plc
21 April 2026
 

 

news release

 

 

EXPERIAN PLC CHAIR APPOINTMENT

21 April 2026 - Experian plc, the global data and technology company, today announces that Adam Crozier will join the Board as an independent Non-Executive Director and Chair Designate from 12 May 2026, and will succeed Mike Rogers as Chair following the conclusion of the Experian plc Annual General Meeting to be held on 22 July 2026. This follows the Company's previous announcement that Mike will retire as a Director and Chair of Experian plc at the conclusion of the AGM, having served on the Board for nine years, including a highly successful seven year tenure as Chair. Adam Crozier will also serve on the Remuneration and Nomination & Corporate Governance Committees, and Chair the latter following the AGM.

Adam Crozier is an experienced Chair and former FTSE 100 Chief Executive with a strong track record of leading large consumer-facing organisations. He is currently Chair of BT Group plc, where he also chairs the Nomination Committee and has responsibility for security oversight. He is also Chair of Kantar Group, a data, analytics and brand consulting company. His career spans senior leadership roles across multiple sectors, with particular experience in brand-led businesses and in driving digital and operational transformation.

Adam was also previously Chair of Whitbread PLC and ASOS plc, and a Non-Executive Director of Sony Group Corporation.

Alison Brittain, Senior Independent Director, said: "Following a comprehensive and rigorous search process, the Board is delighted to appoint Adam as Chair. He brings extensive experience of leading large, complex organisations and a strong track record in data-driven and technology-enabled businesses. Adam's strategic judgement, extensive Chair experience and measured approach position him well to support the Company's continued growth, and the Board looks forward to the perspective he will bring to Experian during the next phase of its development."

Brian Cassin, Chief Executive Officer, said: "On behalf of the Board and everyone at Experian, I would like to thank Mike Rogers for his significant contribution over many years, both as Chair and previously as a Non-Executive Director. His leadership has been instrumental in the Company's development, and we are grateful for his guidance and support.

"We are very pleased to welcome Adam to the Board. He brings extensive leadership and Board experience across large, international businesses, and his insight will be valuable as we continue to execute our strategy and deliver long-term growth."

Adam Crozier said: "I am delighted to be joining Experian at an important stage in its development. The Company has built a strong track record of growth, underpinned by its data, technology and deep customer relationships, and is well positioned to capitalise on the opportunities ahead. I look forward to working with the Board and management team to support continued successful execution of its strategy and delivery of long-term value for stakeholders."

Mike Rogers, Chair, said: "It has been a privilege to serve on the Board of Experian since 2017 and as Chair over the past seven years, and I am pleased to welcome Adam to the Board, and as my successor as Chair. The Company is well positioned for the future, and I am confident it will continue to deliver sustained success. I would like to thank my fellow Board members for their support and wish Experian every success in the years ahead."

The Company confirms, save as disclosed above, that there are no details to be disclosed under UK Listing Rule 6.4.8R, paragraphs (1) to (6) in respect of Adam Crozier's appointment.

Contact:

Experian

Nadia Ridout-Jamieson Investor queries +44 (0)20 3042 4220

Gerry Tschopp, Nick Jones Media queries

 

Teneo

Graeme Wilson and Louise Male +44 (0)20 7353 4200

 

About Experian

Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realise their financial goals and help them to save time and money.

We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.

We invest in talented people and new advanced technologies to unlock the power of data and to innovate. A FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 25,200 people across 33 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAPLEAELKEFA
Date   Source Headline
9th Jun 20264:30 pmRNSDirector/PDMR Shareholding
8th Jun 20263:30 pmRNSDirector/PDMR Shareholding
5th Jun 202611:00 amRNSElections for Second Interim Dividend
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20265:15 pmRNSNotification of issuance of equity securities
29th May 20265:00 pmRNSTotal Voting Rights
29th May 20267:00 amRNSTransaction in Own Shares
28th May 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSTransaction in Own Shares
26th May 202611:45 amRNSDirector/PDMR Shareholding
26th May 20267:00 amRNSTransaction in Own Shares
22nd May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSTransaction in Own Shares
20th May 20267:00 amRNSFull-year financial report
20th May 20267:00 amRNSTransaction in Own Shares
19th May 20267:00 amRNSTransaction in Own Shares
18th May 20267:00 amRNSTransaction in Own Shares
15th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTransaction in Own Shares
13th May 20267:00 amRNSTransaction in Own Shares
12th May 202610:45 amRNSDirector Declaration
12th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSTransaction in Own Shares
7th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 20265:38 pmRNSNotification of issuance of equity securities
30th Apr 20265:14 pmRNSTotal Voting Rights
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSChair appointment
21st Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSTransaction in Own Shares
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20261:15 pmRNSShare repurchase programme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.